Skip to main content
. 2001 Jan 22;2001(1):CD001519. doi: 10.1002/14651858.CD001519

1.4. Analysis.

Comparison 1 Cabergoline versus Bromocriptine, Outcome 4 Schwab and England scale.

Schwab and England scale
Study  
Gershanik 1994 'Off' state: Improvement on cabergoline 11.7 (SD 13.6) v bromocriptine 12.8 (SD 14.5)
 p > 0.05; NS.
 'On' state: Improvement on cabergoline 5.7 (SD 7.5) v bromocriptine 6.1 (SD 9.5)
 p > 0.05; NS.
Gershanik 1994b 'Off' state: Improvement on cabergoline 9.9 (SD 14.4) v bromocriptine 8.5 (SD 12.9)
 p > 0.05; NS.
 'On' state: Improvement on cabergoline 3.0 (SD 9.7) v bromocriptine 3.5 (SD 8.6)
 p > 0.05; NS.
Inzelberg 1996 Improvement on cabergoline (n=22) 1 (SD 10.2) v bromocriptine (n=22) ‐2 (SD 9.5)
 p > 0.05; NS.
Korczyn 1994 'Off' state: Improvement on cabergoline (n=18) 7.78 (SD 19.29) v bromocriptine (n=15) 6.67 (SD 22.72)
 p > 0.05; NS.
 'On' state: Improvement on cabergoline (n=18) ‐0.55 (SD 11.83) v bromocriptine (n=15) 3.33 (SD 12.55)
 p > 0.05; NS.